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Heterotrimeric G proteins relay extracellular cues from heptahelical
transmembrane receptors to downstream effector molecules.
Composed of an  subunit with intrinsic GTPase activity and a 
heterodimer, the trimeric complex dissociates upon receptor-
mediated nucleotide exchange on the  subunit, enabling each
component to engage downstream effector targets for either
activation or inhibition as dictated in a particular pathway. To
mitigate excessive effector engagement and concomitant signal
transmission, the G subunit’s intrinsic activation timer (the rate of
GTP hydrolysis) is regulated spatially and temporally by a class of
GTPase accelerating proteins (GAPs) known as the regulator of G
protein signaling (RGS) family. The array of G protein-coupled
receptors, G subunits, RGS proteins and downstream effectors in
mammalian systems is vast. Understanding the molecular deter-
minants of specificity is critical for a comprehensive mapping of the
G protein system. Here, we present the 2.9 Å crystal structure of the
enigmatic, neuronal G protein Go in the GTP hydrolytic transition
state, complexed with RGS16. Comparison with the 1.89 Å struc-
ture of apo-RGS16, also presented here, reveals plasticity upon Go
binding, the determinants for GAP activity, and the structurally
unique features of Go that likely distinguish it physiologically
from other members of the larger Gi family, affording insight to
receptor, GAP and effector specificity.
G protein  GAP  RGS
Many extracellular cues ranging from photons to neurotrans-mitters are detected with high specificity by G protein-
coupled receptors that in turn elicit an intracellular response by
promoting GTP exchange on the  subunit of a heterotrimeric
G protein. The heterotrimeric G protein, composed of an 
subunit exhibiting endogenous GTPase activity and a het-
erodimeric  subunit, dissociates, enabling each component to
activate downstream effectors until GTP is hydrolyzed on the 
subunit and the heterotrimeric complex reforms. The  subunit’s
endogenous GTP hydrolysis rate is relatively slow, therefore the
cell uses GTPase accelerating proteins (GAPs) to increase the
rate to suit the time scale and magnitude needed for a specific
physiological response.
The regulators of G protein signaling (RGS) proteins are a class
of heterotrimeric G protein GAP first identified in Saccharomyces
cerevisiae (Sst2) and Caenorhabditis elegans (Egl10) (1, 2). Studies,
both biochemical and structural, have shown an overall preference
for RGS domains to bind G subunits in their transition state
(mimicked by the analog GDPAlF4) and to accelerate GTPase
activity by stabilizing the transition state of hydrolysis, thereby
optimizing the endogenous GTPase activity of the G subunit
without directly contributing to the hydrolytic mechanism (3–5).
RGS proteins serve to quench the G protein signal temporally and
spatially, either independently, or coupled (in cis or in trans) to an
effector (6, 7). Thirty-seven RGS proteins have been identified in
the human genome, cataloged into eight subfamilies based on the
protein family the RGS domain resides delineated as RGS sub-
families R4, R7, R12, RZ, and RhoGEFRGS (rgRGS); G protein-
coupled receptor kinases (GRKs); sorting nexins; and Axin (8–10).
Eachmember displays a unique expression and localization pattern
(11). With the number of RGS proteins greatly exceeding the
number of G subunits, RGS proteins are likely to be finely tuned,
titrated, and localized to regulate specific signaling pathways within
a G subunit’s repertoire of effector targets. To mediate the
specificity and fidelity requisite for accurate signal transmission, the
G subunit and its binding partners (GPCR, G, RGS, and
effector) must have specific reciprocating molecular determinants
to minimize the convergence of independent signaling pathways.
Thus, a comprehensive understanding of themolecular basis forG
engagement with its activators, regulators, and effectors is critical
for elucidating specificity determinants. RGS subfamilies pair with
distinct cognate G substrates via unique stereochemical binding
determinants. The RGS subfamilies R4, R7, and R12 engage Gi/o
(3, 12, 13); the R4 subfamily also engages Gq (14); the rgRGS
subfamily engages G12/13 (15); and the RZ subfamily engages Gz
and Gi (3, 16, 17). It is noted that G–RGS interaction modes
observed in R4, R7 and R12 (5, 7) [see accompanying article by
Soundararajan et al. (18)] contrast with the unique interlocking
geometry observed between p115RhoGEF rgRGS and the G13/i1
chimera (19) and the effector-like binding mode observed between
GRK2 and Gq (20).
Go is a member of the Gi family, which includes Gi1-3 and
Gt. Although Go is the most abundant G subunit in the
human brain, little is known about the pathways it is involved in,
in stark contrast to our understanding of Gi1-3 and Gt. Much
of the work on Go to date has implicated a role for its cognate
G subunit in the activation of Ca2 channels (21). Additional
evidence points to Go involvement in signaling from A1-
adenosine receptors (22), dopamine D2 receptors (D2R) (23)
and -opioid signaling (24). A Go effector molecule has been
reported, GRIN1, which promotes growth cone neurite exten-
sion in the mammalian brain (25). The implicated role of Go as
a mediator and regulator of core neurological and cognitive
GPCR-coupled pathways positions Go as a prime target for
pharmaceutical intervention. A molecular understanding of
downstream signaling components is a key step toward identi-
fying potential therapeutic points of drug intervention used
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alone or in combination with GPCR-targeted drugs to minimize
side effects (26).
Here, we report the first crystal structure determination of
Go, presented in the transition state of hydrolysis, complexed
with the R4 subfamily RGS protein RGS16 (27). Go displays a
number of unique determinants that likely affords it specificity
in receptor, RGS, and effector engagement. We discuss the
conserved nature of the RGS GAP mechanism, structural
aspects that confer specificity, and the plasticity of the RGS
domain required to engage and maintain binding during the
transformation of Go from the GTP-bound state to the tran-
sition state by comparing the GoGDPAlF4RGS16 complex
to our independently determined structure of apo-RGS16, also
presented here. The G–RGS interactions noted in our deter-
mination of Go complexed to RGS16 dovetails with specificity
findings presented in an accompanying article by Soundararajan
et al. (18), facilitating the first examination of an RGS protein
complexed to different G subunits.
Results and Discussion
Architecture of the GoRGS16 Complex. Mouse Go was com-
plexed with mouse RGS16 and purified over gel filtration in
the presence of GDP and AlF4 to simulate the transition state
of GTP hydrolysis. The complex was crystallized in the space
group P3221 with two protomers in the asymmetric unit. The
structure was determined by molecular replacement, using
coordinates from the Gi1GDPAlF4RGS4 structure (5) and
refined to a resolution of 2.9 Å. Crystallographic, phasing, and
refinement statistics are presented in supporting information
(SI) Table S1. The architecture of the GoGDPAlF4RGS16
complex resembles those observed in Gi1GDPAlF4RGS4
and Gi1/tGDPAlF4RGS9 structures (Fig. 1) (5, 7). The
RGS domain is positioned almost exclusively on the Go
switches regions I and II. This is the first structural determi-
nation of the Go subunit; thus, it cannot be compared with
previously solved states of Go; but, when compared with the
solved structures of Gi1 and Gt, the Go switch conforma-
tions most closely resembles that observed in the transition
state structures: Gi1GDPAlF4 and GtGDPAlF4 (28,
29). Go retains the overall domain architecture observed in
previously solved G structures delineated by a Ras-like
GTPase domain encompassing three nucleotide-dependent
switch regions and a helical domain, inserted within the
Ras-like domain and tethered by two linker regions (28, 30,
31). RGS16, like RGS4 and RGS9, is delineated by nine
helices, 1–9, segregated into two subdomains: one formed
by helices 1, 2, 3, 8, and 9 and the other by helices 4,
5, 6, and 7 arranged in an antiparallel four-helix bundle (5,
7). The two subdomains are united by a conserved hydropho-
bic interface that constitutes the structure’s core. RGS16 is a
conserved member of the R4 RGS subfamily and retains
central conserved elements that define RGS domains except
for one component, Thr-158, which replaces the conserved
isoleucine or valine found in the equivalent position across all
other RGS members (Fig. S1). Thr-158 is buried in the
hydrophobic core between the two subdomains. It enhances
stabilization through a hydrogen bond to the residue 154
backbone carbonyl and engages the side chain of Phe-93 in a
unique geometry independently confirmed by Soundararajan
et al. (18).
The RGS16 GAP Mechanism. The RGS16 RGS domain engages the
G switch regions via a conserved interface that buttresses their
transition state conformation. The interaction is structurally
similar to that observed in Gi1RGS4 and Gi1/tRGS9 struc-
tures (5, 7). Although the total group of interactions between the
RGS domain and the G switch regions is not identical between
these pairs, key conserved RGS residues are used in identical
interactions (Fig. 2A). Three critical RGS16 residues are in-
volved near the Go active site. RGS16 Asn-90 forms a hydrogen
bond to the hydroxyl group of the Go Thr-183 side chain. In the
GtGDPAlF4 structure, this switch I threonine is rotated
60° from switch II (29). The orientation observed in the
GoRGS16 structure allows the Thr-183 side chain to contact
switch II residues Lys-211 and Glu-208. This clamps switch I and
II together, further stabilizing the transition state conformation
from that observed in the GtGDPAlF4 structure. A second
RGS16 residue, Asp-165, positioned next to switch I, forms a
hydrogen bond to the Thr-183 peptide amide. This interaction
orients the Go Thr-182 backbone carbonyl into the ideal
geometry for hydrogen bonding to the nucleophilic water. A
third RGS16 residue, Asn-130, is inserted between Go residues
Lys-181 and Glu-208. Interactions with these two Go side
chains dictate the orientation of the Asn-130 side chain. In this
conformation, the Asn-130 side chain amide forms a hydrogen
bond with the Go Gln-205 side chain carbonyl. This resolves the
torsional ambiguity of the glutamine side chain, orienting it for
both stabilization of the nucleophilic water and the planar
intermediate. Through these means, RGS16, upon binding Go
in the activated GTP-bound state, reorients Go switches and
the residues involved in GTP hydrolysis from their GTP-bound
state into their transition state conformation.
Posttranslation modifications have been implicated in in-
creased RGS16 GAP activity. One reported modification is
palmitoylation of Cys-98 (Cys-97 in mouse RGS16) (32). Cys-97
Fig. 1. Structure of the GoGDPAlF4RGS16 complex. The GoGDPAlF4RGS16 complex is represented in ribbons format. RGS16 is indicated in gray; Go
GTPase domain is in green with nucleotide-dependent switch regions highlighted in orange; Go helical domain is in purple. Structure at Right is rotated 90°
about the y axis relative to the structure at Left.
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projects off helix 4 into the RGS core. A dramatic reorganization
of the RGS fold would be required for palmitoylation to occur
and any resulting palmitoyl group would project toward the G
subunit. A second modification, phosphorylation of Tyr-168
(Tyr 167 in mouse RGS16) was also reported to increase RGS16
GAP activity (33). The Tyr-167 hydroxyl engages the backbone
carbonyl groups of Trp-61 and Arg-62 on helix 1. Tyr-167
phosphorylation would likely precipitate a torsional rotation
outwards from its buried position. No apparent contacts be-
tween phospho-Tyr-167 and a G subunit would be predicted,
but allosteric modulation of RGS16 GAP activity may result.
G–RGS Specificity Determinants. Interactions between the RGS
domains and G subunits determined to date are centered
primarily on G switch regions I and II. Residues in switches I
and II that contribute to RGS binding are nearly invariant across
G subunits and do not vary at all across Gi members Go,
Gi1, Gi2, Gi3, and Gt (Fig. S2). Outside the Gi family, RGS
specificity is likely to be modulated by the substitution of a lysine
at position 181 (relative to Go) with either a proline or alanine
as found in Gq and G12/13 family members or a leucine as
found in the RGS-GAP incompetent family Gs. RGS–G
interactions, however, are not limited exclusively to the
nucleotide-dependent switch regions, but may also involve elec-
trostatic interactions with components of the helical domain
(Fig. 2B and Fig. S2) (7). A higher degree of variation, both
within the composition of the G helical domain and the RGS
residues that contact it, provides a platform for specificity
proximal to, but independent of, the nucleotide-dependent
switch regions.
G–RGS complex structures determined to date have all used
different G subunits and different RGS members. In an
accompanying article by Soundararajan et al. (18), the human
cognate pair Gi1RGS16 is presented, enabling us to directly
compare the interactions between Gi family members (Gi1
and Go) bound to the same RGS member. Analysis of contacts
between RGS16 and Gi members shows that a core set of
interactions involving 11 pairs of residues is constant for both
Gi1 and Go (Fig. 2B). A number of Gi1–RGS16 pairs are
unique, including interactions formed between Arg-236–Asp-
137 and Arg-90–Glu-135. In the latter pair, an arginine, specific
to Gi1 and Gi3, spans the interaction distance that could not
be attained by the equivalent Go residue, Thr-90. Unique
Go–RGS16 interactions include an interaction with the GT-
Pase domain Thr-182–Asp-165; interactions with the helical
domain including A residues Asp-65–Lys-172, Ser-75–Lys-164,
and Arg-86–Glu-134; and an interaction between RGS16 Lys-
164 and Thr-117 on the Go B–C loop. In addition, residues
are used in van der Waals contacts between Go and RGS16,
including Go His-236 (an alanine or valine residue in Gi family
counterparts) that contacts the side chain of RGS16 Asp-132
forming a 4Åelectrostatic interaction between its Ngroup and the
Asp-132  carbonyl. As discussed below, prime differences
between Go and Gi1 reside in the helical domain, specifically
in terms of side chain diversity and the organization of the
B–C region. The differential set of interactions between
RGS16 and Go vs. Gi1 is reflected in the total area of solvent
accessible surface buried upon complex formation. Analysis
of the two Gi1RGS16 structure protomers shows each com-
plex burying 738 Å2 and 802 Å2, respectively. In contrast,
GoRGS16 structure protomers bury 897 Å2 and 873 Å2,
respectively, an average of 115 Å2 more than those observed in
the Gi1RGS16 structures, the majority of the differential due
to RGS domain–Go helical domain contacts. The G helical
domain’s role in conferring specificity is likely to be one of a
number of factors involved. Although binding determinants
between the helical domain and the RGS domain 7 and 8
helices have been observed in Gi1RGS4 (5), Gt/i1RGS9 (7),
and the Gi3RGS8 and Gi3RGS10 structures (see ref. 18), no
contacts were observed between the G helical domain and the
RGS domain in the Gi1RGS1 and Gi1RGS16 structures.
Conformational Changes in RGS16. The independently determined
structure of RGS16 alone and in complex with Go allows
analysis of any conformational changes that occur upon binding
the Go subunit. A least-squares fitting of the two RGS16
structures over the RGS domain shows little variation in the
backbone of the segments that contact Go (Fig. 3). Minor
movement is noted along the backbone at the 7–8 linker and
N-terminal to 6. Examination of the RGS16 backbone outside
Fig. 2. Go–RGS16 contacts and the RGS domain GAP mechanism. (A)
Stick-and-ribbons diagram of the Go GTP binding pocket occupied by the
transition state analog of GTP hydrolysis; GDPAlF4 is shown with Mg2 and
the attacking water. Go is shown in green and orange (switch regions). RGS16
is shown in purple. RGS16 residues do not contact the GTP or attacking water
directly; instead they buttress the endogenous catalytic residues of Go,
stabilizing their conformation in the transition state. (B) Comparative 4 Å
electrostatic interaction matrix between RGS16 and G subunits. Electrostatic
interactions between mouse Go and mouse RGS16 are indicated in green.
Electrostatic interactions between human Gi1 and human RGS16 are indi-
cated in yellow (PDB ID code 2IK8; see ref. 18). G switch residues are boxed
in orange; helical domain residues are boxed in purple. Interactions that occur
in one or both crystallographic protomers are included for both Go–RGS16
and Gi1–RGS16.
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the binding region shows a minor reorientation of the N- and
C-terminal subdomain formed by 1, 2, 3, 8, and 9 . In the
apo state, this region is pivoted away from the Go binding face.
This is primarily due to movements in 1, 2, and 9. The N- and
C-terminal subdomain is more highly ordered in the apo state
with electron density evident for more residues at the N and C
termini, potentially indicative of subdomain plasticity when
complexed with Go. RGS16 side chains involved in Go switch
stabilization undergo a variety of conformational changes. Res-
idues along 3 and 4, including Glu-85, Phe-86, Glu-89, and
Asn-90 undergo modest changes in orientation. In contrast,
significant conformational changes are noted for Glu-125 and
Asn-130 with large torsional movements (120° for Asn-130) to
facilitate hydrogen bonding to cognate Go residues. The reori-
entation of Asn-130 is likely coupled to movement of its binding
partner, the Go residue Gln-205. The corresponding residue in
Gt (Gln-200) was observed to undergo a conformational
change between the GTP-bound state and the transition state
(29). RGS16 may recognize the key Go residue Gln-205 in the
active GTP-bound state and dynamically reposition it into the
transition state observed in the GoGDPAlF4RGS16 struc-
ture. RGS16 side chain movements of note also occur along the
6 helix, including His-133 and Glu-134 and along the 1 helix,
where the Leu-161 side chain rotates toward the binding inter-
face interior, and Asp-165 and Arg-169, linked in a stabilized
triad with Glu-85 via the Arg-169 -guanido group. This triad
undergoes a planar shift of their hydrogen-bonding network
facilitated by a rearrangement of Arg-169 into an alternative
rotamer via rotations along the C–C and C–N bonds. The
orientation of this triad mediates the critical interaction between
RGS16Asp-165 and the switch I Thr-183 backbone amide, which
in turn positions the Thr-182 backbone carbonyl into optimal
geometry for transition state stabilization of the attacking water.
The plasticity observed in the RGS16 RGS domain between apo
and Go-complexed states has also been observed in RGS9 and
Fig. 4. Unique structural determinants in the Go helical domain. (A)
Structural alignment of Go and Gi1 bound to GDPAlF4, coordinates taken
from their respective complex structures with RGS16 and RGS4 [PDB ID code
1AGR (5)] and displayed as a C trace. Go is colored as in Fig. 1A except that
the divergent B–C loop is shown in red. Gi1 is shown in gray except for the
comparativeB–C loop, which is shown in blue. The structural alignment was
performed with PyMol. (B) Structural alignment as in A, zoomed in on the
B–C loop region. Gi/12 [PDB ID code 1ZCA (36)] is included, with its respec-
tive Bd–C loop region shown in yellow. (C) Representation of Go in ribbon
format (Left, colored as in Fig. 1A) for orientation and in CPK (Right) with the
GTPase domain, helical domain, and switch regions colored white, light gray,
and dark gray respectively. Residues identical across Gi1-3 and Gt but not
identical in Go are mapped in red. Residues identical across Gi1-3 but not
identical in Go are mapped in blue. Two orientations, related by 180° rota-
tions, are displayed vertically.
Fig. 3. Determinants of RGS16 binding and conformational plasticity. Struc-
tural alignment of mouse RGS16 in the free (gray) and Go-bound (slate)
states. The C trace is presented for both structures, with key residues used in
the Go interaction represented in stick format. The structural alignment was
performed with PyMol.
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the independently determined structures of RGS16 in the com-
panion article by Soundararajan et al. (18). Domain and side
chain rearrangements are a key mechanistic feature of the RGS
domain. Although the RGS domain has the highest affinity for
G in the transition state, it must be able to recognize and bind
the activated GTP-bound state and maintain engagement as it
reconfigures the complex into the transition state. Subsequently,
after releasing G-GDP, it must reconfigure, priming itself for
subsequent engagement of another activated G subunit.
Structural Features of Go. Go is a member of the Gi family and
is most closely related to Gi1 (34, 35). A comparison of identical
vs. nonidentical residues between Go and the Gi family shows
that the majority of differences occur in the helical domain,
primarily in the B helix and the B–C loop (Fig. 4C and Fig. S2).
Although no evidence exists that the helical domain serves any
function in regard to effector coupling, the differences between
Go and Gi1 raises that possibility. A least-squares fitting of the
two molecules reveals a large difference in the B–C region. The
difference relative to Gi1 and Gt is primarily the result of a
proline insertion N-terminal to C, displacing the B–C region
6 Å from its comparable position in Gi1 and Gt (Fig. 4 A and
B). Temperature factors for this region of Go are slightly elevated
above the average main chain temperature factor, likely indicative
of mobility within this region. The B–C region is a central point
of divergence among G subunits, particularly for the G12/13
family caused by insertions in the B–C loop (Fig. 1B). The
structures of chimeric Gi/12 and Gi/13 with intact G12 and G13
helical domains reveal a loop for G12 and an additional helix for
G13 that extends from B and C toward the switch regions of the
GTPase domain (Fig. 4B) (36). It is likely that diversity within the
B–C region is a critical element for GEF, effector, and GAP
specificity given its proximity to the nucleotide-dependent switch
regions. In strong support for this observation is the finding that
GoLoco guanine nucleotide dissociation inhibitor (GDI) motifs
target G subunits with specificity determinants mediated by the
G helical domain and the GoLoco C-terminal region. GoLoco
motifs from RGS12, RGS14, and AGS3 exert GDI activity on
Gi1-3 but not Go (37–39). The helical domain’s role as a deter-
minant in GDI GoLoco specificity was confirmed through analysis
of a Gi1–Go chimera in which the helical domain of Gi1 was
replaced with the Go helical domain, thus preventing GoLoco-
mediated GDI activity on the Gi1 GTPase domain (39).
To delineate residues that functionally distinguish Go from
other Gi family members, wemapped residues that are identical
across Gi1-3 and Gt but are not identical in Go and a second
tier of residues that are identical across Gi1-3 but are not
identical in Go (Figs. 1B and 4C). The majority of residues
unique to Go under these criteria map to the helical domain
along the B–C region. Additional unique residues reside on
the opposite face of the G subunit, although most also diverge
from Gi1-3 in Gt. Although the nucleotide switch regions are
highly conserved, a number of unique residues occur in Go
including Asp-218 in switch II and Gln-233, His-236, Thr-250,
and Thr-251 in switch III. The threonine residues on switch III
reside proximal to RGS16, implicating them as key nucleotide-
dependent determinants for effector–GAP coupling. His-236 of
switch III (alanine or valine in Gi family counterparts) engages
RGS16 as mentioned above, contributing van derWaals contacts
and electrostatic interactions with RGS16 Asp-132. Gln-233 is
buried between the GTPase domain and the helical domain.
Asp-218 of switch II (a glycine in Gi family counterparts) is
solvent exposed, and, although distal to the RGS domain (14 Å
separation), it may also contribute to nucleotide-dependent
effector–GAP coupling determinants.
Conclusion
The heterotrimeric G protein  subunit is a molecular switch
efficiently designed to transmit signaling information from up-
stream receptors to downstream effectors with high fidelity. G
protein  subunits must orchestrate a unique signal transduction
pathway amidst hundreds of G protein-coupled receptors and
scores of downstream effectors. Functionally, this requires the
encoding of higher level specificity. The requirements placed on
the G subunit include time-dependent activation (endogenous
GTPase activity), conformational change to regulate binding
partners (nucleotide-dependent switch regions), and binding
specificity (unique structural determinants). To regulate  sub-
unit activation temporally and spatially, GAP proteins, including
members of the RGS family, are used to bind and enhance the
 subunit’s endogenous GTPase activity. Although RGS pro-
teins quench G protein activity in vitro, it is critical at the cellular
level to ensure signal transmission to downstream effectors
before inactivation. This paradigm is best illustrated in the visual
system where effector–GAP coupling between phosphodiester-
ase  and RGS9-G5 ensures efficient, temporally regulated
Gt-mediated signal transmission. To extend this paradigm to
other G subunits, specific effector binding determinants prox-
imal to and nonoverlapping with the  subunit’s RGS binding
domain are critical. As illustrated in our structure of Go and by
comparison with Gi and G12/13 family members, the  sub-
unit’s helical domain is a key component with all of the requisite
features to facilitate specificity in both effector–GAP coupling
and receptor-mediated GEF activity.
Highly enriched in the brain, Go likely engages a variety of
RGS proteins across anatomical regions, each RGS pairing
honed to desensitize Go on time scales calibrated for specific
neuronal and cognitive tasks. RGS16 localization is specific for
the principal relay and midline/intralaminar thalamic nuclei and
hypothalamic suprachiasmatic nucleus, sites critical for circadian
rhythms and processing sensory input (40). RGS16 and Go are
uniquely positioned to modulate information dissemination in
the brain. Analysis of RGS16 knockout mice or use of inhibitors
specifically designed to perturb Go or RGS16 function will
provide great insight into the neuronal mechanisms the pair
govern.
Materials and Methods: Protein Expression and Purification
Details regarding the expression and purification of H6RGS1653-180,Go, com-
plex formation, crystallization, data collection, structure determination, and
refinement are in SI Materials and Methods.
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